Isophthaloyl dichloride is a colorless liquid with a pungent odor. It is used as a monomer in the synthesis of various polymers, including polyesters, polyamides, and polyimides. Isophthaloyl dichloride is synthesized by the reaction of isophthalic acid with thionyl chloride. It is an important chemical intermediate in the production of high-performance polymers with excellent thermal stability and mechanical strength. Due to its versatility and potential for creating advanced materials, isophthaloyl dichloride is a subject of extensive research in the fields of polymer science and materials engineering.'
ID Source | ID |
---|---|
PubMed CID | 7451 |
CHEMBL ID | 1885739 |
SCHEMBL ID | 27510 |
MeSH ID | M0109140 |
Synonym |
---|
nsc41884 |
isophthalic acid chloride |
m-phthalyl dichloride |
1,3-benzenedicarbonyl chloride |
isophthalic chloride |
99-63-8 |
1,3-benzenedicarbonyl dichloride |
m-phthalic dichloride |
isothaloyl chloride |
m-benzenedicarbonyl chloride |
wln: gvr cvg |
isophthaloyl dichloride |
isophthaloyl chloride |
m-phthaloyl chloride |
isophthalyl dichloride |
nsc-41884 |
isophthalic acid dichloride |
isophthalyl chloride |
dichlorid kyseliny isoftalove [czech] |
nsc 41884 |
brn 0638342 |
1,3-benzenedicarboxylic acid, dichloride |
meta-phthalyl dichloride |
einecs 202-774-7 |
hsdb 5326 |
isophthaloyl chloride, >=99% |
NCGC00164011-01 |
benzene-1,3-dicarbonyl chloride |
I0159 |
A846057 |
AKOS004904996 |
NCGC00164011-02 |
NCGC00257157-01 |
dtxcid406641 |
tox21_303056 |
cas-99-63-8 |
dtxsid3026641 , |
NCGC00259145-01 |
tox21_201596 |
30942-71-3 |
ec 202-774-7 |
unii-6a3ldj6cl3 |
dichlorid kyseliny isoftalove |
6a3ldj6cl3 , |
FT-0627454 |
1,3-benzenedicarbonyl chloride [hsdb] |
m-benzenedicarbonyl chlorid |
m-phthaloyl dichloride |
1,3-bis(chlorocarbonyl)benzene |
1,3-di(chlorocarbonyl)benzene |
3-(2-morpholinoethylamino)-6-phenyl-pyridazine-4-carbonitrile |
SCHEMBL27510 |
isophthaloylchloride |
isophthalic dichloride |
iso-phthaloyl chloride |
benzene-1,3-dicarbonyl dichloride |
m-phthalyl chloride |
W-100026 |
CHEMBL1885739 |
mfcd00000678 |
isophthaloyl chloride, purum, >=98.0% (at) |
STR04660 |
Q27264395 |
EN300-19830 |
F87312 |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
glucocorticoid receptor [Homo sapiens] | Homo sapiens (human) | Potency | 0.0891 | 0.0002 | 14.3764 | 60.0339 | AID588532 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 43.2771 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552 |
retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 24.5382 | 0.0008 | 17.5051 | 59.3239 | AID1159527 |
estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 14.8082 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841; AID1259401 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 50.1187 | 0.3758 | 27.4851 | 61.6524 | AID588526 |
estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 21.8751 | 0.0002 | 29.3054 | 16,493.5996 | AID743069 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 21.8751 | 0.0010 | 19.4141 | 70.9645 | AID743191 |
thyroid hormone receptor beta isoform a | Homo sapiens (human) | Potency | 50.1187 | 0.0100 | 39.5371 | 1,122.0200 | AID588545 |
Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 68.5896 | 0.0023 | 19.5956 | 74.0614 | AID651631 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (30.40) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |